India’s government would not purchase Pfizer or Moderna Covid-19 vaccines, according to sources


According to three government sources, India’s government would not purchase Covid-19 vaccines from Pfizer-BioNTech and Moderna, mostly because local production of more inexpensive and easier-to-store vaccines has increased. That effectively implies that the world’s most popular vaccinations, which their manufacturers have promised not to sell to private parties during the epidemic, will be unavailable for the time being in the world’s two most populous countries, China and India.
According to two individuals, the Indian government has also turned down the US firms’ demands for legal protection against any negative effects from the usage of their injections, which are presently exclusively produced in the US or Europe. In India, no firm has ever gotten such protection.
“Previously, there was a scarcity, and there was a demand,” one of the individuals said, referring to India’s request for vaccinations from firms in April when illnesses surged, and injections were in short supply.
“Their cost will be exorbitant. Why should we accept their circumstances?”
According to another source: “Pfizer and Moderna vaccines will not be purchased by the government. Following the required regulatory permissions, they are allowed to form private partnerships. However, we are unable to provide sovereign indemnity “.
In India, a Pfizer spokeswoman said that talks were ongoing and that the company was still committed to delivering the vaccine to the nation.


Please enter your comment!
Please enter your name here

Enable Google Transliteration.(To type in English, press Ctrl+g)